Stereotaxis
STXS | AMEX
$0.80
-$0.04 (-5.12%)
At close: Nov 16, 2026, 4:00 PM ET
$0.82
+$0.02 (+2.50%)
After-hours:
Nov 16, 2026, 7:10 PM ET
-5.12%
(1D)No price chart data available for 1D timeframe.
Rating
38
-1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #582/1021 (Top 57%)
Key Statistics
Market Data
Market Cap $80.43M
1D Range
0.80 0.87
52W Range
0.80 2.79
Valuation (TTM)
PE -3.33
PB 3.77
EV/EBITDA -4.00
Valuation (NTM)
Forward PE N/A
Forward PEG 0.48
Price Target $3.50
Cash Flow
FCF Yield -19.3%
SBC Adj. FCF Yield -30.1%
SBC Impact -55.9%
Margins
Gross Margin 52.5%
Operating Margin -69.4%
FCF Margin -49.2%
Growth (CAGR)
Revenue 3Y | 5Y 2.2% |
-1.3%
Dil EPS 3Y | 5Y 5.7% |
-1.2%
FCF 3Y | 5Y -30.1% |
-9.1%
Returns
ROA -27.2%
ROE -115.8%
ROIC -42.3%
Financial Health
Net Cash
$1.51M
Current Ratio 1.08
Interest Coverage -497.02
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary arter...
Sector Healthcare
Industry Medical - Instruments & Supplies
Employees 131
IPO Date Aug 12, 2004
Website www.stereotaxis.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
-$0.07
Miss -31.26%
YoY:
-133.33% REV
$8.93M
Miss -7.03%
YoY:
+19.57%Next Earnings
Mar 8, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$3.50
Upside
+337.50%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove STXS